The FDA has granted Fast Track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection.

Chlamydia is an infection caused by the bacterium Chlamydia trachomatis. It's one of the most widespread of all sexually transmitted diseases, according to the Centers for Disease Control and ...

Sanofi SNY announced that the FDA has granted a fast-track designation to its mRNA vaccine candidate for the prevention of ...

An elderly man in the Netherlands ended up suffering serious pneumonia after being infected with a bacteria strain not seen in humans before.

Are you searching for effective medications to treat 'Chlamydia Trachomatis'? This comprehensive guide provides the latest information on medications-both generic and branded-that are essential ...

This decision underscores the need for a preventative measure against the chlamydia, which affects millions worldwide.

US FDA grants fast track designation to Sanofi’s mRNA vaccine candidate for prevention of chlamydia infection: Paris Friday, March 28, 2025, 12:00 Hrs [IST] The US Food and Drug ...

Sanofi’s chlamydia vaccine candidate was designed to protect against primary genital tract infection and reinfection by the bacterium Chlamydia trachomatis. The Food and Drug Administration (FDA ...